| Literature DB >> 3154464 |
S Schleibner1, H Welter, D Abendroth, W D Illner, G Hillebrand, E Albert, H Schneeberger, M Wiesel, W Land.
Abstract
The use of different immunosuppressive protocols (high-dose/low-dose CsA) has little effect on first cadaveric transplants in nonsensitized patients. However, low-dose CsA induction treatment reduces early nephrotoxic crises. There is a clear benefit of quadruple drug induction treatment for retransplants and sensitized transplant candidates. Steroid-free immunosuppressive therapy can be applied to a majority of long-term patients.Entities:
Mesh:
Substances:
Year: 1988 PMID: 3154464
Source DB: PubMed Journal: Clin Transpl ISSN: 0890-9016